Soumettre la recherche
Mettre en ligne
Memorial Hermann Team A
•
Télécharger en tant que PPTX, PDF
•
2 j'aime
•
2,056 vues
Carolina Thomas
Suivre
Signaler
Partager
Signaler
Partager
1 sur 21
Télécharger maintenant
Recommandé
In the spring of 2011 I was on a team that designed an accountable care organization for Memorial Hermann Health Systems.
Memorial Hermann ACO Creation
Memorial Hermann ACO Creation
Jess Jacobs
A case study of consolidation between two different regional hospitals. It's impact to the resident of community, to peripheral clinics and to the staffs. A scenario analysis to find out best solution
A Strategic Case Study of Hospital Administration: hospital consolidation
A Strategic Case Study of Hospital Administration: hospital consolidation
Wayne Wei
When it comes to postmarket surveillance (PMS), it’s common for the costs to outweigh the value. But, by working with the right team, you’ll be able to execute a study that maximizes return on investment and minimizes the financial impact of conducting further observational research. Postmarket study challenges that must be addressed include enrollment delays, patient attrition, long-term follow-up, resourcing demands and global payor requirements. This session will provide a case study of one orthopaedic company’s seamless transition between postmarket approval and post-approval studies.
How to Make Postmarket Surveillance More Cost Effective
How to Make Postmarket Surveillance More Cost Effective
April Bright
The Aequitas Group Capabilities Overview Q409
The Aequitas Group Capabilities Overview Q409
bmeunier9
Presentation to KMUK 2011 conference, June 2011
Establishing a Knowledge Hub to enable evidence-based decision making in heal...
Establishing a Knowledge Hub to enable evidence-based decision making in heal...
Alison Turner
Intelligent Clinical Supply Forecasting and Simulations through IRT-March02-2...
Intelligent Clinical Supply Forecasting and Simulations through IRT-March02-2...
Praveen Chand
Presentation describing NIH-funded informationist project at UMass Medical School. Given at eScience Professional Development Day, November 2012.
UMass Medical School, Lamar Soutter Library: Informationist
UMass Medical School, Lamar Soutter Library: Informationist
Sally Gore, Lamar Soutter Library, UMass Medical School
HealthBlitz Project List 0515 Flyer
HealthBlitz Project List 0515 Flyer
Elizabeth Ashley (Bush) Ramsey
Recommandé
In the spring of 2011 I was on a team that designed an accountable care organization for Memorial Hermann Health Systems.
Memorial Hermann ACO Creation
Memorial Hermann ACO Creation
Jess Jacobs
A case study of consolidation between two different regional hospitals. It's impact to the resident of community, to peripheral clinics and to the staffs. A scenario analysis to find out best solution
A Strategic Case Study of Hospital Administration: hospital consolidation
A Strategic Case Study of Hospital Administration: hospital consolidation
Wayne Wei
When it comes to postmarket surveillance (PMS), it’s common for the costs to outweigh the value. But, by working with the right team, you’ll be able to execute a study that maximizes return on investment and minimizes the financial impact of conducting further observational research. Postmarket study challenges that must be addressed include enrollment delays, patient attrition, long-term follow-up, resourcing demands and global payor requirements. This session will provide a case study of one orthopaedic company’s seamless transition between postmarket approval and post-approval studies.
How to Make Postmarket Surveillance More Cost Effective
How to Make Postmarket Surveillance More Cost Effective
April Bright
The Aequitas Group Capabilities Overview Q409
The Aequitas Group Capabilities Overview Q409
bmeunier9
Presentation to KMUK 2011 conference, June 2011
Establishing a Knowledge Hub to enable evidence-based decision making in heal...
Establishing a Knowledge Hub to enable evidence-based decision making in heal...
Alison Turner
Intelligent Clinical Supply Forecasting and Simulations through IRT-March02-2...
Intelligent Clinical Supply Forecasting and Simulations through IRT-March02-2...
Praveen Chand
Presentation describing NIH-funded informationist project at UMass Medical School. Given at eScience Professional Development Day, November 2012.
UMass Medical School, Lamar Soutter Library: Informationist
UMass Medical School, Lamar Soutter Library: Informationist
Sally Gore, Lamar Soutter Library, UMass Medical School
HealthBlitz Project List 0515 Flyer
HealthBlitz Project List 0515 Flyer
Elizabeth Ashley (Bush) Ramsey
By Nariman Nasser, Director of Participant Recruitment Service, CTSI, UCSF
Best Practices in Clinical Study Recruitment
Best Practices in Clinical Study Recruitment
CTSI at UCSF
Lecture given as part of a healthcare leadership development course. Objective was to link the personal drive that brings a physician or nurse to pursue leadership opportunities with the reality of how to think about innovative change and healthcare transformation.
Physician leadership - thoughts from a physician executive
Physician leadership - thoughts from a physician executive
Michael Wagner, MD FACP
This presentation highlights how the UCSF Clinical and Translational Science Institute (CTSI) enhances and facilitates early-stage research efforts at UCSF and UCSF/industry partnerships - to develop new treatments, diagnostics and prevention.
Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...
Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...
CTSI at UCSF
how to write a resume, do\'s and don\'ts
Tailoring Your Resume For Today’S Pantsuits
Tailoring Your Resume For Today’S Pantsuits
Laura Roybal
Quality and cost improvements require the intelligent use of financial and clinical data coupled with education for multi-disciplinary teams who are driving process improvements. Once a data warehouse is established, healthcare organizations need to set up multi-disciplinary clinical, financial, and IT specialist teams to make the best use of the data. Sometimes, financial involvement is minimized or even excluded for a number of reasons that can turn out to be counterproductive. However, including financial measurements and participation up front can help enhance the recognized value and sustainability of quality improvement or waste reduction efforts. the In this session you will learn keys to success and real-life examples of linking clinical, financial and patient satisfaction data via multi-disciplinary teams that produce impressive results.
The Imperative of Linking Clinical and Financial Data to Improve Outcomes - H...
The Imperative of Linking Clinical and Financial Data to Improve Outcomes - H...
Health Catalyst
Strategic planning model
Strategic planning model
vkbypo
B. McLaughlin Associates, Inc. (BMA) has been a provider of customized, cost-effective clinical research support for over 18 years. Our services for drug, biologics, and device studies include Study Management, Regulatory and Financial Document Collection and Review, Regulatory Document Audits, Clinical Study Contract/Patient Budget Negotiation, Informed Consent Creation, Review and Change Management, Drug and Biologics Temperature Monitoring (Cold Chain), Data Management, and Clinical Scientist Support. We recognize the importance of a successfully run clinical trial and have the industry experienced staff to enhance your study team and create positive results. Our Study Analysts, Data Analysts, and Study Managers will professionally run your projects to ensure timely completion of all contracted tasks, while keeping quality, accountability, and compliance paramount. Whether your outsourcing requirements are for the full life cycle of a clinical trial or just for a specific need, BMA is here to provide a flexible solution. Our goal is to provide world class support services that keep your projects on time, within budget, and compliant to all regulatory authorities.
BMA Presentation 2011_Handout
BMA Presentation 2011_Handout
BMA
Let 1000 flowers bloom: Support for the current “system”
Let 1000 flowers bloom: Support for the current “system”
Cochrane.Collaboration
Presentation with initial thoughts about the need for pharma company's to develop a new business model
Towards Value Innovation In Pharma SFE Conference London 062007
Towards Value Innovation In Pharma SFE Conference London 062007
A.R.J. (Rob) Halkes
This presentation, given by our President at the 2018 MGMA Annual Meeting, explains why cultural fit is so important and how to create a physician recruitment blueprint that focuses on fit.
Focus on Fit: A Cultural Blueprint for Successful Physician Recruitment
Focus on Fit: A Cultural Blueprint for Successful Physician Recruitment
Jackson Physician Search
Command Leadership
Command Leadership
mswtx
April 2010 Speech at the NACUBO Higher Education Accounting Forum
Nacubo Heaf Speech On Dashboards
Nacubo Heaf Speech On Dashboards
Nick Wallace
2010 Mastery Session
NTI2010 Increasing Quality And Safety
NTI2010 Increasing Quality And Safety
Todd_Grivetti
The IFPAC Session: Controlling excipient impact during the product lifecycle. Excipients enable the delivery of actives as a pharmaceutical product. Quality by Design requires that the impact of excipient variability on finished product quality be minimized, or, as paraphrased by Tobyn: - What matters doesn’t vary, and what varies doesn’t matter. This parallels the current practice of categorizing excipients into critical vs non-critical, the assumption being that the latter do not impact the finished product Critical Quality Attributes. This binary classification of criticality has been criticized as too simple and it is not uncommon to observe excursions in finished product quality correlating with variability of a so-called non-critical excipient. The complexity of the excipients, and the products into which they are formulated, contributes to this uncertainty. For excipients, what varies may not have mattered prior to approval, but may come to matter later in the product lifecycle, especially for continuously manufactured products with real time release. Excipients, even if fully compliant and manufactured under GMP, represent a reservoir of special cause variability in finished product quality. By definition this can only be addressed via the Control Strategy. Risk management requires continuous multivariate monitoring of finished product and raw materials to maintain quality and model fidelity.
NIPTE Roadmap 2017 Discussion @ IFPAC 2017
NIPTE Roadmap 2017 Discussion @ IFPAC 2017
Ajaz Hussain
Ks Manpower Planning
Ks Manpower Planning
ksways
Understanding Markets, Market Demand, and the Marketing Environment
Understanding Markets, Market Demand, and the Marketing Environment
Understanding Markets, Market Demand, and the Marketing Environment
Sumit Pradhan
This is the presentation given by Dr Charles Pain, Director Health Systems Improvement, Clinical Excellence Commission, at the recent Team Health Consultatin Forum.
Building effective teams - Dr Charles Pain
Building effective teams - Dr Charles Pain
byersd
3 marketing research
3 marketing research
rrhhoohhii
Introduction to HST921: Information Technology in the Healthcare System of the Future
Hst921 Intro 2009 Dec 16
Hst921 Intro 2009 Dec 16
slockemd
Presentation at the Royal Statistical Society's International Conference, Newcastle, September 2013. Paul Askew speakingdata.org.uk paul.askew@speakingdata.org.uk A Framework Understating Statistical Performance This paper presents a framework for understanding, managing and presenting statistical performance data. It provides a manageable, but multidimensional way of organising a range of possible analysis and assessment to provide a rounded and balanced picture for effective understanding and communication. This is founded on a broad scope of assessment, based around three key analytical elements: trend, benchmark and target. That is the first multidimensional perspective. Each of those three key elements are then further disaggregated in a range of appropriate ways to provide a second, more disaggregate, multidimensional analytical assessment. There is then a third more tailored and specific multidimensional disaggregation to provide additional detailed statistical insight. This draws on practical application of this framework in a range of sectors including health, policing and education, and across the public sector spectrum including Central Government, regulation and local service delivery, and in both strategic and operational environments. This provides an overall framework to manage the communication and understanding of statistical performance, and focussed on public data. It provides a framework to build a balanced communication of statistical analysis and messages, and at the same time it provides the user and recipient of statistics and statistical analysis with a framework to both understand and question the scope and content of statistical communication.
A Framework for Statistical Performance
A Framework for Statistical Performance
Paul Askew
Contenu connexe
Similaire à Memorial Hermann Team A
By Nariman Nasser, Director of Participant Recruitment Service, CTSI, UCSF
Best Practices in Clinical Study Recruitment
Best Practices in Clinical Study Recruitment
CTSI at UCSF
Lecture given as part of a healthcare leadership development course. Objective was to link the personal drive that brings a physician or nurse to pursue leadership opportunities with the reality of how to think about innovative change and healthcare transformation.
Physician leadership - thoughts from a physician executive
Physician leadership - thoughts from a physician executive
Michael Wagner, MD FACP
This presentation highlights how the UCSF Clinical and Translational Science Institute (CTSI) enhances and facilitates early-stage research efforts at UCSF and UCSF/industry partnerships - to develop new treatments, diagnostics and prevention.
Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...
Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...
CTSI at UCSF
how to write a resume, do\'s and don\'ts
Tailoring Your Resume For Today’S Pantsuits
Tailoring Your Resume For Today’S Pantsuits
Laura Roybal
Quality and cost improvements require the intelligent use of financial and clinical data coupled with education for multi-disciplinary teams who are driving process improvements. Once a data warehouse is established, healthcare organizations need to set up multi-disciplinary clinical, financial, and IT specialist teams to make the best use of the data. Sometimes, financial involvement is minimized or even excluded for a number of reasons that can turn out to be counterproductive. However, including financial measurements and participation up front can help enhance the recognized value and sustainability of quality improvement or waste reduction efforts. the In this session you will learn keys to success and real-life examples of linking clinical, financial and patient satisfaction data via multi-disciplinary teams that produce impressive results.
The Imperative of Linking Clinical and Financial Data to Improve Outcomes - H...
The Imperative of Linking Clinical and Financial Data to Improve Outcomes - H...
Health Catalyst
Strategic planning model
Strategic planning model
vkbypo
B. McLaughlin Associates, Inc. (BMA) has been a provider of customized, cost-effective clinical research support for over 18 years. Our services for drug, biologics, and device studies include Study Management, Regulatory and Financial Document Collection and Review, Regulatory Document Audits, Clinical Study Contract/Patient Budget Negotiation, Informed Consent Creation, Review and Change Management, Drug and Biologics Temperature Monitoring (Cold Chain), Data Management, and Clinical Scientist Support. We recognize the importance of a successfully run clinical trial and have the industry experienced staff to enhance your study team and create positive results. Our Study Analysts, Data Analysts, and Study Managers will professionally run your projects to ensure timely completion of all contracted tasks, while keeping quality, accountability, and compliance paramount. Whether your outsourcing requirements are for the full life cycle of a clinical trial or just for a specific need, BMA is here to provide a flexible solution. Our goal is to provide world class support services that keep your projects on time, within budget, and compliant to all regulatory authorities.
BMA Presentation 2011_Handout
BMA Presentation 2011_Handout
BMA
Let 1000 flowers bloom: Support for the current “system”
Let 1000 flowers bloom: Support for the current “system”
Cochrane.Collaboration
Presentation with initial thoughts about the need for pharma company's to develop a new business model
Towards Value Innovation In Pharma SFE Conference London 062007
Towards Value Innovation In Pharma SFE Conference London 062007
A.R.J. (Rob) Halkes
This presentation, given by our President at the 2018 MGMA Annual Meeting, explains why cultural fit is so important and how to create a physician recruitment blueprint that focuses on fit.
Focus on Fit: A Cultural Blueprint for Successful Physician Recruitment
Focus on Fit: A Cultural Blueprint for Successful Physician Recruitment
Jackson Physician Search
Command Leadership
Command Leadership
mswtx
April 2010 Speech at the NACUBO Higher Education Accounting Forum
Nacubo Heaf Speech On Dashboards
Nacubo Heaf Speech On Dashboards
Nick Wallace
2010 Mastery Session
NTI2010 Increasing Quality And Safety
NTI2010 Increasing Quality And Safety
Todd_Grivetti
The IFPAC Session: Controlling excipient impact during the product lifecycle. Excipients enable the delivery of actives as a pharmaceutical product. Quality by Design requires that the impact of excipient variability on finished product quality be minimized, or, as paraphrased by Tobyn: - What matters doesn’t vary, and what varies doesn’t matter. This parallels the current practice of categorizing excipients into critical vs non-critical, the assumption being that the latter do not impact the finished product Critical Quality Attributes. This binary classification of criticality has been criticized as too simple and it is not uncommon to observe excursions in finished product quality correlating with variability of a so-called non-critical excipient. The complexity of the excipients, and the products into which they are formulated, contributes to this uncertainty. For excipients, what varies may not have mattered prior to approval, but may come to matter later in the product lifecycle, especially for continuously manufactured products with real time release. Excipients, even if fully compliant and manufactured under GMP, represent a reservoir of special cause variability in finished product quality. By definition this can only be addressed via the Control Strategy. Risk management requires continuous multivariate monitoring of finished product and raw materials to maintain quality and model fidelity.
NIPTE Roadmap 2017 Discussion @ IFPAC 2017
NIPTE Roadmap 2017 Discussion @ IFPAC 2017
Ajaz Hussain
Ks Manpower Planning
Ks Manpower Planning
ksways
Understanding Markets, Market Demand, and the Marketing Environment
Understanding Markets, Market Demand, and the Marketing Environment
Understanding Markets, Market Demand, and the Marketing Environment
Sumit Pradhan
This is the presentation given by Dr Charles Pain, Director Health Systems Improvement, Clinical Excellence Commission, at the recent Team Health Consultatin Forum.
Building effective teams - Dr Charles Pain
Building effective teams - Dr Charles Pain
byersd
3 marketing research
3 marketing research
rrhhoohhii
Introduction to HST921: Information Technology in the Healthcare System of the Future
Hst921 Intro 2009 Dec 16
Hst921 Intro 2009 Dec 16
slockemd
Presentation at the Royal Statistical Society's International Conference, Newcastle, September 2013. Paul Askew speakingdata.org.uk paul.askew@speakingdata.org.uk A Framework Understating Statistical Performance This paper presents a framework for understanding, managing and presenting statistical performance data. It provides a manageable, but multidimensional way of organising a range of possible analysis and assessment to provide a rounded and balanced picture for effective understanding and communication. This is founded on a broad scope of assessment, based around three key analytical elements: trend, benchmark and target. That is the first multidimensional perspective. Each of those three key elements are then further disaggregated in a range of appropriate ways to provide a second, more disaggregate, multidimensional analytical assessment. There is then a third more tailored and specific multidimensional disaggregation to provide additional detailed statistical insight. This draws on practical application of this framework in a range of sectors including health, policing and education, and across the public sector spectrum including Central Government, regulation and local service delivery, and in both strategic and operational environments. This provides an overall framework to manage the communication and understanding of statistical performance, and focussed on public data. It provides a framework to build a balanced communication of statistical analysis and messages, and at the same time it provides the user and recipient of statistics and statistical analysis with a framework to both understand and question the scope and content of statistical communication.
A Framework for Statistical Performance
A Framework for Statistical Performance
Paul Askew
Similaire à Memorial Hermann Team A
(20)
Best Practices in Clinical Study Recruitment
Best Practices in Clinical Study Recruitment
Physician leadership - thoughts from a physician executive
Physician leadership - thoughts from a physician executive
Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...
Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...
Tailoring Your Resume For Today’S Pantsuits
Tailoring Your Resume For Today’S Pantsuits
The Imperative of Linking Clinical and Financial Data to Improve Outcomes - H...
The Imperative of Linking Clinical and Financial Data to Improve Outcomes - H...
Strategic planning model
Strategic planning model
BMA Presentation 2011_Handout
BMA Presentation 2011_Handout
Let 1000 flowers bloom: Support for the current “system”
Let 1000 flowers bloom: Support for the current “system”
Towards Value Innovation In Pharma SFE Conference London 062007
Towards Value Innovation In Pharma SFE Conference London 062007
Focus on Fit: A Cultural Blueprint for Successful Physician Recruitment
Focus on Fit: A Cultural Blueprint for Successful Physician Recruitment
Command Leadership
Command Leadership
Nacubo Heaf Speech On Dashboards
Nacubo Heaf Speech On Dashboards
NTI2010 Increasing Quality And Safety
NTI2010 Increasing Quality And Safety
NIPTE Roadmap 2017 Discussion @ IFPAC 2017
NIPTE Roadmap 2017 Discussion @ IFPAC 2017
Ks Manpower Planning
Ks Manpower Planning
Understanding Markets, Market Demand, and the Marketing Environment
Understanding Markets, Market Demand, and the Marketing Environment
Building effective teams - Dr Charles Pain
Building effective teams - Dr Charles Pain
3 marketing research
3 marketing research
Hst921 Intro 2009 Dec 16
Hst921 Intro 2009 Dec 16
A Framework for Statistical Performance
A Framework for Statistical Performance
Memorial Hermann Team A
1.
Marketing Proposal Brandon
Ferguson Matthew Mason Sarah Pope Carolina Thomas Alina Tkachova
2.
3.
Proposal
4.
Methodology
5.
Deliverables
6.
Timeline and
Budget
7.
Break-Even Analysis
8.
9.
10.
7 Cancer Treatment
Centers
11.
3 Heart and
Vascular Institutes
12.
13.
14.
Proposal
15.
16.
Enhance patient experience
17.
Research best practices
and industry trends
18.
19.
20.
Customer experience follow-up
21.
22.
23.
Technologies
24.
Programs
25.
26.
27.
28.
29.
Timeline and Budget
30.
Timeline and Budget
May 2010 April 2010 July 2010 June 2010
31.
Break-Even Analysis
32.
33.
870 days
to recover project expense
34.
35.
Questions?
Télécharger maintenant